Acne & Rosacea

For Emmy Graber, MD, MBA, selecting an appropriate oral antibiotic for dermatological conditions necessitates a careful consideration of efficacy, duration, combination therapy, and resistance issues.

Growing apprehensions surrounding antibiotic resistance in acne and rosacea treatments, coupled with their linked adverse effects, have prompted a closer examination of their use. Emmy Graber, MD, MBA...

The study looked at transgender men, transgender women, and nonbinary individuals.

New research sheds light on the lived experiences of transgender individuals who have acne. 

"While acne is common in transgender and gender-diverse people and is associated with gender-affirming hor...

The retrospective analysis provided insight for healthcare providers and those with ADHD and ASD.

Both male and females who were diagnosed with attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) showed different risks for acne and eczema, according to a study.

"Our ...

Is there an association between steroid creams and osteoporosis?

Recently released study data found that higher doses of topical corticosteroids, such as those often used to treat inflammatory skin disorders, are tied to increased risks for osteoporosis and bone fr...

The company is on track to submit an NDA to the FDA for DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) to treat rosacea at the end of the year.

Journey Medical Corporation has successfully completed its pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) for DFD-29 (Minocycline Hydrochloride Modified Releas...

The partnership aims to improve the design of protein-protein modulators through Artificial Intelligence to identify new therapeutic approaches for the treatment of skin diseases.

Almirall S.A. (BME: ALM), Barcelona Supercomputing Center-Centro Nacional de Supercomputación (BSC-CNS) and Nostrum Biodiscovery are joining forces to explore artificial intelligence (AI) and machine ...

Absci will apply its de novo generative AI technology to create and commercialize therapeutic candidates for two dermatological targets.

Almirall S.A. and Absci Corporation, a generative artificial intelligence (AI) drug creation company, are teaming up to develop and commercialize AI-designed therapeutics to treat dermatological disea...

The Society announced support for one new initiative and continued funding for two more.

The National Rosacea Society (NRS) has announced that it will contribute funding for one new study, continue funding for two ongoing studies, as part of its grant program to advance rosacea research. 

Only 3 in 10 respondents reported having visited a dermatologist for help, according to the data.

A new survey reveals defeatist attitudes about treatment among people with mild-to-moderate acne, despite feelings of self-consciousness. Among the 1,003 survey respondents ages 13-55, only three in 1...

Cabtreo is the first and only FDA-approved fixed-dose, triple-combination topical treatment for acne.

The U.S. Food and Drug Administration (FDA) has approved CABTREO (clindamycin phosphate, adapalene, and benzoyl peroxide) topical gel for the topical treatment of acne vulgaris in patients aged 12 and...